TY - JOUR
T1 - A randomized trial of a hepatitis care coordination model in methadone maintenance treatment
AU - Masson, Carmen L.
AU - Delucchi, Kevin L.
AU - McKnight, Courtney
AU - Hettema, Jennifer
AU - Khalili, Mandana
AU - Min, Albert
AU - Jordan, Ashly E.
AU - Pepper, Nicole
AU - Hall, Jessica
AU - Hengl, Nicholas S.
AU - Young, Christopher
AU - Shopshire, Michael S.
AU - Manuel, Jennifer K.
AU - Coffin, Lara
AU - Hammer, Hali
AU - Shapiro, Bradley
AU - Seewald, Randy M.
AU - Bodenheimer, Henry C.
AU - Sorensen, James L.
AU - Des Jarlais, Don C.
AU - Perlman, David C.
PY - 2013/10
Y1 - 2013/10
N2 - Objectives. We evaluated the efficacy of a hepatitis care coordination intervention to improve linkage to hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination and clinical evaluation of hepatitis C virus (HCV) infection among methadone maintenance patients. Methods. We conducted a randomized controlled trial of 489 participants from methadone maintenance treatment programs in San Francisco, California, and New York City from February 2008 through June 2011. We randomized participants to a control arm (n = 245) and an intervention arm (n = 244), which included on-site screening, motivational-enhanced education and counseling, on-site vaccination, and case management services. Results. Compared with the control group, intervention group participants were significantly more likely (odds ratio [OR] = 41.8; 95% confidence interval [CI] = 19.4, 90.0) to receive their first vaccine dose within 30 days and to receive an HCV evaluation within 6 months (OR = 4.10; 95% CI = 2.35, 7.17). A combined intervention adherence outcome that measured adherence to HAV-HBV vaccination, HCV evaluation, or both strongly favored the intervention group (OR = 8.70; 95% CI = 5.56, 13.61). Conclusions. Hepatitis care coordination was efficacious in increasing adherence to HAV-HBV vaccination and HCV clinical evaluation among methadone patients.
AB - Objectives. We evaluated the efficacy of a hepatitis care coordination intervention to improve linkage to hepatitis A virus (HAV) and hepatitis B virus (HBV) vaccination and clinical evaluation of hepatitis C virus (HCV) infection among methadone maintenance patients. Methods. We conducted a randomized controlled trial of 489 participants from methadone maintenance treatment programs in San Francisco, California, and New York City from February 2008 through June 2011. We randomized participants to a control arm (n = 245) and an intervention arm (n = 244), which included on-site screening, motivational-enhanced education and counseling, on-site vaccination, and case management services. Results. Compared with the control group, intervention group participants were significantly more likely (odds ratio [OR] = 41.8; 95% confidence interval [CI] = 19.4, 90.0) to receive their first vaccine dose within 30 days and to receive an HCV evaluation within 6 months (OR = 4.10; 95% CI = 2.35, 7.17). A combined intervention adherence outcome that measured adherence to HAV-HBV vaccination, HCV evaluation, or both strongly favored the intervention group (OR = 8.70; 95% CI = 5.56, 13.61). Conclusions. Hepatitis care coordination was efficacious in increasing adherence to HAV-HBV vaccination and HCV clinical evaluation among methadone patients.
UR - http://www.scopus.com/inward/record.url?scp=84879781393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879781393&partnerID=8YFLogxK
U2 - 10.2105/AJPH.2013.301458
DO - 10.2105/AJPH.2013.301458
M3 - Article
C2 - 23947319
AN - SCOPUS:84879781393
SN - 0090-0036
VL - 103
SP - e81-e88
JO - American journal of public health
JF - American journal of public health
IS - 10
ER -